GAP-43 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

7,567 results for “GAP-43”

Trials

View all 2835 →

Extension Program for Bay 43-9006

9 participants · First posted Apr 14, 2008

BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma

10 participants · First posted Feb 6, 2006

[18F]ACI-19626 PET in TDP-43 Proteinopathies

45 participants · First posted Mar 24, 2025

Drugs

View all 399 →

Investigational

ALMB-0166

GAP-31

GAP-107B8

Organizations

View all 180 →

Nohla Therapeutics, Inc.

United States

复星医药（徐州）有限公司

Inspirna, Inc.

United States

News

View all 4153 →

Vaccinex Secures $60 Million to Advance Phase 2b Trial of Alzheimer's Drug Pepinemab

Aldeyra Therapeutics Plans Reproxalap NDA Resubmission for Dry Eye Disease Following FDA Feedback

BRAVYL (Oral Fasudil) Shows Promise in Reducing TDP-43 Spread in ALS Patients

Page 1 of 757